Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
2016 ◽
Vol 17
(7)
◽
pp. 917-927
◽
Toni K Choueiri
◽
Bernard Escudier
◽
Thomas Powles
◽
Nizar M Tannir
◽
Paul N Mainwaring
◽
...
2020 ◽
Vol 126
(18)
◽
pp. 4156-4167
◽
Robert J. Motzer
◽
Bernard Escudier
◽
Saby George
◽
Hans J. Hammers
◽
Sandhya Srinivas
◽
...
2016 ◽
Vol 17
(7)
◽
pp. 994-1003
◽
David Cella
◽
Viktor Grünwald
◽
Paul Nathan
◽
Justin Doan
◽
Homa Dastani
◽
...
Brian Rini
◽
Sumanta K. Pal
◽
Bernard J. Escudier
◽
Michael B. Atkins
◽
Thomas E. Hutson
◽
...
David Cella
◽
Robert J Motzer
◽
Cristina Suarez
◽
Steven I Blum
◽
Flavia Ejzykowicz
◽
...
2019 ◽
Vol 393
(10189)
◽
pp. 2404-2415
◽
Brian I Rini
◽
Thomas Powles
◽
Michael B Atkins
◽
Bernard Escudier
◽
David F McDermott
◽
...
2020 ◽
Vol 21
(1)
◽
pp. 95-104
◽
Brian I Rini
◽
Sumanta K Pal
◽
Bernard J Escudier
◽
Michael B Atkins
◽
Thomas E Hutson
◽
...
2009 ◽
Vol 8
(4)
◽
pp. 184
◽
M. Staehler
◽
G. Procopio
◽
U. Keilholz
◽
S. Negrier
◽
C. Szczylik
◽
...
2020 ◽
Vol 8
(16)
◽
pp. 1037-1037
Mary E. Westerman
◽
Christopher G. Wood
2020 ◽
Vol 21
(12)
◽
pp. 1563-1573
◽
Thomas Powles
◽
Elizabeth R Plimack
◽
Denis Soulières
◽
Tom Waddell
◽
Viktor Stus
◽
...
2015 ◽
Vol 51
◽
pp. S708
◽
P. Sharma
◽
B. Escudier
◽
D.F. McDermott
◽
S. George
◽
H.J. Hammers
◽
...